NEW YORK (GenomeWeb) – Biocept said today that it will collaborate with University of Minnesota researcher Shilpa Gupta on a study evaluating the company's Target Selector liquid biopsy platform for detection of PD-L1 and androgen receptor (AR) expression in bladder and prostate cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.